About Saratoga Schenectady Gastroenterology Associates
Clinical Trials at Saratoga Schenectady Gastroenterology Associates
During the past decade, Saratoga Schenectady Gastroenterology Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Saratoga Schenectady Gastroenterology Associates"
#1 collaborator was "Crohn's and Colitis Foundation" with 2 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Dartmouth College" with 1 trials as a collaborator and "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Saratoga Schenectady Gastroenterology Associates
According to Clinical.Site data, the most researched conditions in "Saratoga Schenectady Gastroenterology Associates" are
"Crohn Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Crohn's Disease" (1 trials), "Inflammatory Bowel Diseases" (1 trials) and "Ulcerative Colitis and Crohn's Disease" (1 trials). Many other conditions were trialed in "Saratoga Schenectady Gastroenterology Associates" in a lesser frequency.
Clinical Trials Intervention Types at Saratoga Schenectady Gastroenterology Associates
Most popular intervention types in "Saratoga Schenectady Gastroenterology Associates" are "Other" (2 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Adalimumab (40 mg)" (1 trials), "Other Biologic Agents" (1 trials), "Placebo for Adalimumab" (1 trials), "Placebo for Ustekinumab" (1 trials) and "Pragmatic" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saratoga Schenectady Gastroenterology Associates
The vast majority of trials in "Saratoga Schenectady Gastroenterology Associates" are
4 trials for "All" genders.
Clinical Trials Status at Saratoga Schenectady Gastroenterology Associates
Currently, there are NaN active trials in "Saratoga Schenectady Gastroenterology Associates".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 2 completed trials in Saratoga Schenectady Gastroenterology Associates,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saratoga Schenectady Gastroenterology Associates, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".